TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED

Altre lingue TaiGen Biopharmaceuticals Holdings Limited

Azioni

4157

KYG866171005

Prezzo di chiusura Taipei Exchange Altri mercati azionari 00:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
15,4 ^TWD	-0,65%		-6,38%	+1,32%

15/03	TaiGen Biopharmaceuticals Holdings Limited riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
2023	TaiGen Biopharmaceuticals Holdings Limited riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23/08/23
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	09/05/22
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22
TaiGen Biopharmaceuticals Turns to Profit in 2021	17/03/22
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021	30/08/21
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	11/05/21
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2020	25/03/21
TaiGen Biotechnology Company, Limited Partners with GPCR Therapeutics, Inc. to Develop Burixafor & Taigexyn(R)	09/11/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020	04/11/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020	04/08/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	29/04/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019	19/03/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019	10/11/19
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019	12/08/19
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2019	07/05/19

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue TaiGen Biopharmaceuticals Holdings Limited

Azioni

4157

KYG866171005

Altre lingue

Filtri